ID   TEC-4
AC   CVCL_A0RU
SY   1G4; TEC4; Tumor endothelial cell antibody 4
DR   ATCC; HB-12312
DR   Wikidata; Q108821367
RX   Patent=US5660827;
RX   Patent=US5877289;
RX   PubMed=9815965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12312.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
RX   PubMed=9815965;
RA   Burrows, Francis J.
RA   Derbyshire, Elaine J.
RA   Tazzari, Pier Luigi
RA   Amlot, Peter
RA   Gazdar, Adi F.
RA   King, Steven W.
RA   Letarte, Michelle
RA   Vitetta, Ellen S.
RA   Thorpe, Philip Edward
RT   "Up-regulation of endoglin on vascular endothelial cells in human
RT   solid tumors: implications for diagnosis and therapy.";
RL   Clin. Cancer Res. 1:1623-1634(1995).
//
RX   Patent=US5660827;
RA   Thorpe, Philip Edward
RA   Burrows, Francis J.
RT   "Antibodies that bind to endoglin.";
RL   Patent number US5660827, 26-Aug-1997.
//
RX   Patent=US5877289;
RA   Thorpe, Philip Edward
RA   Edgington, Thomas Scott
RT   "Tissue factor compositions and ligands for the specific coagulation
RT   of vasculature.";
RL   Patent number US5877289, 02-Mar-1999.
//